---

Related Articles:

Efficacy of olopatadine HCI 0.1%, ketotifen fumarate 0.025%, epinastine HCI 0.05%, emedastine 0.05% and fluorometholone acetate 0.1% ophthalmic solutions for seasonal allergic conjunctivitis: a placebo-controlled environmental trial.

2009-08-01

[Acta Ophthalmol. 87(5) , 549-54, (2009)]

Emedastine difumarate versus loratadine in chronic idiopathic urticaria: a randomized, double-blind, controlled European multicentre clinical trial.

2006-01-01

[Eur. J. Dermatol. 16(6) , 649-54, (2006)]

Suplatast tosilate inhibits eosinophil production and recruitment into the skin in murine contact sensitivity.

2003-09-01

[Clin. Immunol. 108(3) , 257-62, (2003)]

[In vitro effects of antiallergic eyedrops on complement activation induced by particulate matter].

2003-04-01

[J. Fr. Ophtalmol. 26(4) , 328-36, (2003)]

A randomized, double-blind, placebo-controlled comparison of emedastine 0.05% ophthalmic solution with loratadine 10 mg and their combination in the human conjunctival allergen challenge model.

2002-03-01

[Clin. Ther. 24(3) , 445-56, (2002)]